Introduction: The purpose of this study was to develop and validate a predictive model for the early identification of nonresponders to a 12-month lifestyle change program in clinical practice.
Methods: Investigators identified lifestyle change program participants in the electronic health records of a large healthcare delivery system between 2010 and 2017. Nonresponse was defined as weight gain or no weight loss at 12 months from the program initiation (baseline). Logistic regression with percentage weight change at 2-12 weeks from baseline was used as an independent predictor of nonresponse. Baseline demographics and clinical characteristics were also tested as potential predictors. The authors performed ten-fold cross-validation for model assessment and examined model performance with the area under the receiver operating characteristic curve, sensitivity, specificity, and positive and negative predictive values. The analyses were conducted in 2019.
Results: Among 947 program participants, 30% were classified as nonresponders at 12 months. The model with the best discrimination of responders from nonresponders included weight change at 12 weeks from baseline as the sole predictor (area under the receiver operating characteristic curve, 0.789). Sensitivity and positive predictive value were maximized at 0.56 (specificity and negative predictive value, 0.81 each).
Conclusions: In a cohort of lifestyle change program participants from clinical practice, percentage weight change at 12 weeks from baseline can serve as a single indicator of nonresponse at the completion of the 12-month program. Clinicians can easily apply this algorithm to identify and assess participants in potential need of adjunctive or alternative therapy to maximize treatment outcomes.
Copyright © 2019 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.
Nonresponse to 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention: clinical prediction and generation of a risk scoring system.Am J Obstet Gynecol. 2016 Nov;215(5):622.e1-622.e8. doi: 10.1016/j.ajog.2016.07.013. Epub 2016 Jul 11. Am J Obstet Gynecol. 2016. PMID: 27418444 Free PMC article. Clinical Trial.
Short-term weight trajectories and long-term weight outcomes from a lifestyle intervention in real-world clinical practice.Transl Behav Med. 2019 Aug 1:ibz118. doi: 10.1093/tbm/ibz118. Online ahead of print. Transl Behav Med. 2019. PMID: 31369678
Early evaluation of patient risk for substantial weight gain during olanzapine treatment for schizophrenia, schizophreniform, or schizoaffective disorder.BMC Psychiatry. 2008 Sep 15;8:78. doi: 10.1186/1471-244X-8-78. BMC Psychiatry. 2008. PMID: 18793440 Free PMC article.
Screening for High Blood Pressure in Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Dec. Report No.: 13-05194-EF-1. Agency for Healthcare Research and Quality (US). 2014. PMID: 25632496 Free Books & Documents. Review.
Transtheoretical model stages of change for dietary and physical exercise modification in weight loss management for overweight and obese adults.Cochrane Database Syst Rev. 2014 Feb 5;(2):CD008066. doi: 10.1002/14651858.CD008066.pub3. Cochrane Database Syst Rev. 2014. PMID: 24500864 Review.